lenvatinib,sunitinib,everolimus,pembrolizumab
merck,pfizer,eisai
['clear study']
updated clear study results with median 4 year follow-up in #kidneycancer #asco23 
Medical Oncologist at @UFHealthCancer and Assistant Professor of Medicine at @UF